Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares fell 4.52% to $42.63 on Tuesday, underperforming the broader market as the S&P 500 and Dow Jones rose. This marks the stock's third consecutive day of losses, with BSX trading significantly below its 52-week high. While competitors Abbott, Medtronic, and Stryker also declined, Boston Scientific's performance was mixed relative to peers. Trading volume remained slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) shed 4.52% to $42.63 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,543.59 and the Dow Jones Industrial Average rising 0.02% to 52,508.27.
This was the stock's third consecutive day of losses.
Boston Scientific Corp. closed 61.07% short of its 52-week high of $109.50, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 3.42% to $88.96, Medtronic PLC (MDT) fell 5.11% to $79.30, and Stryker Corp. (SYK) fell 6.15% to $311.07.
Trading volume (19.9 M) remained 919,778 below its 50-day average volume of 20.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-14-26 1645ET